Ondansetron Safety During Breastfeeding

Evidence-Based Recommendation

• The Association of Anaesthetists 2020 guideline recommends ondansetron as a safe anti-emetic medication for breastfeeding women, based on pharmacokinetic principles and clinical experience, despite the lack of human studies on its transfer into breast milk 1, 2, 3
• The guideline categorizes ondansetron as a drug that can be used in breastfeeding women without any special precautions or waiting periods, based on animal data and clinical experience 4, 5

Key Clinical Points

• No human data exists on ondansetron transfer into breast milk, though animal studies provide some information, and the lack of human studies does not preclude its use 5
• The Association of Anaesthetists guideline explicitly endorses the safety of ondansetron for breastfeeding women, based on pharmacokinetic principles and clinical experience 1, 2, 3

Practical Application

• No waiting period is required before resuming breastfeeding after ondansetron administration, according to the Association of Anaesthetists guideline 1, 2, 3
• Ondansetron can be used for both acute management and peri-operative nausea/vomiting in breastfeeding women, as listed alongside other commonly used anti-emetics that are compatible with breastfeeding 6
• The medication is considered compatible with breastfeeding, along with other anti-emetics such as granisetron, cyclizine, prochlorperazine, dexamethasone, metoclopramide, and domperidone, according to the Association of Anaesthetists guideline 1, 2, 3

Important Caveats

• Special caution is warranted in patients with underlying heart disease due to potential QT interval prolongation, a general precaution not specific to breastfeeding, according to the Journal of Allergy and Clinical Immunology 6
• The cardiac risk associated with ondansetron applies to the mother's safety rather than infant exposure through breast milk, as noted in the Journal of Allergy and Clinical Immunology 6
• The guideline's endorsement of ondansetron applies to standard clinical doses used for nausea and vomiting management, according to the Association of Anaesthetists guideline 1, 2, 3
• Both intravenous and oral formulations of ondansetron are considered acceptable for use in breastfeeding women, as noted in the Journal of Allergy and Clinical Immunology 6